Bone Biologics Corp Sustainability Reports
Bone Biologics Corp. is a medical device company focused on bone regeneration in spinal fusion using recombinant human protein solutions. Its lead product platform centers on the rhNELL-1 growth factor growth device targeted for surgical use.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
2 reports from 2023 to 2024
Company Profile
Bone Biologics Corp. is a medical device company focused on bone regeneration in spinal fusion using recombinant human protein solutions. Its lead product platform centers on the rhNELL-1 growth factor growth device targeted for surgical use.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
